Crohn's Disease

Show Only Open Trials
1.

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

  • Study Status: Open to Enrollment
  • Sponsor: Janssen
  • Disease Status and/or Stage: Moderate to Severe Crohn's Disease
2.

Evaluation of PROCHYMAL Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease

  • Study Status: Open to Enrollment
  • Sponsor: Osiris
  • Disease Status and/or Stage: Moderate to Severe Crohn's Disease
  • Protocol ID: Osiris 603
3.

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

  • Study Status: Open to Enrollment
  • Sponsor: Elan Pharmaceuticals
  • Disease Status and/or Stage: Crohn's Disease Being Treated with TYSABRI
4.

The Multi-Center African American IBD Study (MAAIS)

  • Study Status: Open to Enrollment
  • Sponsor: National Institutes of Digestive Diseases and Kidney (NIDDK)
  • Disease Status and/or Stage: African-Americans with IBD, a Family Member with IBD, or Healthy Volunteers
5.

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease

  • Study Status: Open to Enrollment
  • Sponsor: Crohn’s Colitis Foundation Clinical Alliance
  • Disease Status and/or Stage: Pregnant Women with Crohn's Disease or Ulcerative Colitis

Top of page